ES2161914T3 - Uso de piperina como mejorador de la absorcion gastrointestinal. - Google Patents

Uso de piperina como mejorador de la absorcion gastrointestinal.

Info

Publication number
ES2161914T3
ES2161914T3 ES95939489T ES95939489T ES2161914T3 ES 2161914 T3 ES2161914 T3 ES 2161914T3 ES 95939489 T ES95939489 T ES 95939489T ES 95939489 T ES95939489 T ES 95939489T ES 2161914 T3 ES2161914 T3 ES 2161914T3
Authority
ES
Spain
Prior art keywords
piperine
gastrointestinal absorption
improver
compositions
nutrients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95939489T
Other languages
English (en)
Inventor
Muhammed Majeed
Vladimir Badmaev
R Jayanagar Rajendran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sabinsa Corp
Original Assignee
Sabinsa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27014435&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2161914(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/393,738 external-priority patent/US5536506A/en
Application filed by Sabinsa Corp filed Critical Sabinsa Corp
Application granted granted Critical
Publication of ES2161914T3 publication Critical patent/ES2161914T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/10—Natural spices, flavouring agents or condiments; Extracts thereof
    • A23L27/11—Natural spices, flavouring agents or condiments; Extracts thereof obtained by solvent extraction
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Botany (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

COMPOSICIONES Y METODOS PARA LA MEJORA DE LA ABSORCION GASTROINTESTINAL Y LA UTILIZACION SISTEMICA DE NUTRIENTES Y DE SUPLEMENTOS NUTRICIONALES EN LOS QUE LAS COMPOSICIONES CONTIENEN UN MINIMO DEL 98 % DEL ALCALOIDE PIPERINA PURO. EL METODO COMPRENDE LA ADMINISTRACION ORAL, TOPICA O PARENTERAL DE COMPOSICIONES DE LA INVENCION. SE DESCUBRE ASIMISMO UN NUEVO PROCESO PARA LA EXTRACCION Y PURIFICACION DE PIPERINA.
ES95939489T 1995-02-24 1995-11-06 Uso de piperina como mejorador de la absorcion gastrointestinal. Expired - Lifetime ES2161914T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/393,738 US5536506A (en) 1995-02-24 1995-02-24 Use of piperine to increase the bioavailability of nutritional compounds
US08/550,496 US5744161A (en) 1995-02-24 1995-10-30 Use of piperine as a bioavailability enhancer

Publications (1)

Publication Number Publication Date
ES2161914T3 true ES2161914T3 (es) 2001-12-16

Family

ID=27014435

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95939489T Expired - Lifetime ES2161914T3 (es) 1995-02-24 1995-11-06 Uso de piperina como mejorador de la absorcion gastrointestinal.

Country Status (12)

Country Link
US (2) US5744161A (es)
EP (1) EP0810868B1 (es)
JP (1) JP3953513B2 (es)
AT (1) ATE204757T1 (es)
AU (1) AU4128796A (es)
CA (1) CA2247467C (es)
DE (1) DE69522477T2 (es)
DK (1) DK0810868T3 (es)
ES (1) ES2161914T3 (es)
GR (1) GR3036711T3 (es)
PT (1) PT810868E (es)
WO (1) WO1996025939A1 (es)

Families Citing this family (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6488956B1 (en) * 1994-06-20 2002-12-03 Drugtech Corporation Multi-vitamin and mineral supplements for women
US6352713B1 (en) * 1999-12-01 2002-03-05 Drugtech Corporation Nutritional composition
US5744161A (en) * 1995-02-24 1998-04-28 Sabinsa Corporation Use of piperine as a bioavailability enhancer
US6060060A (en) * 1997-01-31 2000-05-09 Bmb Patent Holding Corporation Analgesic compositions from sweet peppers and methods of use thereof
US5962030A (en) 1997-03-07 1999-10-05 Akesis Pharmaceuticals, Inc. Dietary supplement and method of treatment for diabetic control
US5789401A (en) * 1997-08-08 1998-08-04 Nutrition 21 High-dose chromium/biotin treatment of type II diabetes
ATE304364T1 (de) * 1997-08-08 2005-09-15 Nutrition 21 Chromium/biotin behandlung von typ-ii diabetes
GB9815177D0 (en) 1998-07-13 1998-09-09 King S College London Treatment of skin disorders
US6680391B2 (en) 1998-07-13 2004-01-20 Btg International Limited Treatment of skin conditions
GB2370989A (en) 2001-01-16 2002-07-17 Btg Int Ltd Piperine analogues for the treatment of skin conditions
WO2000015051A1 (en) * 1998-09-14 2000-03-23 Interhealth Nutraceuticals, Inc. Hydroxycitric acid compositions
US6852760B1 (en) 1998-09-17 2005-02-08 Akesis Pharmaceuticals, Inc. Compositions and methods for treatment for glucose metabolism disorders
US6376549B1 (en) 1998-09-17 2002-04-23 Akesis Pharmaceuticals, Inc. Metforimin-containing compositions for the treatment of diabetes
US6086888A (en) * 1998-12-22 2000-07-11 Bmb Patent Holding Corporation Analgesic compositions from sweet bell peppers and methods of use thereof
US6054585A (en) * 1998-12-23 2000-04-25 Sabinsa Corporation Process for making high purity piperine for nutritional use
US6534086B1 (en) * 2000-03-06 2003-03-18 Metagenics, Inc. Composition and method for treatment of inflammation and pain in mammals
US7112609B2 (en) * 1999-06-01 2006-09-26 Drugtech Corporation Nutritional supplements
US6258846B1 (en) * 1999-06-01 2001-07-10 Drugtech Corporation Nutritional supplements
US6187333B1 (en) * 1999-09-20 2001-02-13 Diabex, Inc. Method for treating, controlling, and preventing diabetes mellitus
US20030236300A1 (en) * 1999-10-27 2003-12-25 Yale University Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
DE10196213T1 (de) * 2000-05-19 2003-04-30 Sabinsa Corp Verfahren erhöhter Bioverfügbarkeit von Nährstoffen und pharmazeutische Präparationen mit Tetrahydropiperin und Analoga und Derivaten davon
EP1296682A4 (en) * 2000-06-28 2004-11-10 Bakulesh Mafatlal Khamar CHEMOSENSIZING AGENT
DE60128238T2 (de) * 2000-06-28 2008-01-03 Kikkoman Corp., Noda Antiallergische verbindungen und diese enthaltende medikamente, nahrungsmittel, getränke oder kosmetika sowie verfahren zu deren herstellung
EP1326588B1 (de) * 2000-09-20 2023-08-30 Catalent Germany Eberbach GmbH Orale zubereitungsformen von extrakten aus boswellia
JP4858889B2 (ja) * 2000-10-20 2012-01-18 有限会社大長企画 栄養剤、消化器剤
US6576253B2 (en) 2000-12-05 2003-06-10 Pbm Pharmaceuticals, Inc. Food bars containing nutritional supplements
US20060062864A1 (en) * 2000-12-28 2006-03-23 Mccleary Edward L Weight loss composition and method
US6579866B2 (en) * 2000-12-28 2003-06-17 Mccleary Larry Composition and method for modulating nutrient partitioning
US20040043013A1 (en) 2000-12-28 2004-03-04 Mccleary Edward Larry Metabolic uncoupling therapy
IT1320180B1 (it) 2000-12-29 2003-11-26 Hunza Di Marazzita Maria Carme Preparazioni nutrizionali e terapeutiche dotate di attivita'antiossidante ed in grado di controllare gli eccessi ponderali e
JP4227409B2 (ja) * 2001-01-30 2009-02-18 サビンサ コーポレーション 安定なルテインおよびルテイン誘導体の組成物を得るためのプロセス
AU2002308648A1 (en) * 2001-05-04 2002-11-18 Theralife, Inc. Compositions and methods for reducing cytotoxicity and inhibiting angiogenesis
WO2003028747A1 (en) * 2001-10-04 2003-04-10 Harris Dennis H Ingestible nerve and circulatory nutritional formulation
US20030099626A1 (en) * 2001-11-20 2003-05-29 Health Education Corporation Nutrient absorption enhancing compositions and methods
AU2002366588A1 (en) * 2001-12-13 2003-06-23 Council Of Scientific And Industrial Research Bioavailability enhancing activity of zingiber officinale linn and its extracts/fractions thereof
KR20040089733A (ko) * 2002-03-12 2004-10-21 카운슬 오브 사이언티픽 앤드 인더스트리얼 리서치 쿠미눔 시미눔 및 이의 추출물 및 분획물의생체이용률/생체내효능 증진 활성
EA009214B1 (ru) * 2002-04-04 2007-12-28 Индравадан Амбалал Моди Фармацевтическая композиция, набор и способ лечения вич-инфекций
US6979468B1 (en) 2002-12-06 2005-12-27 Sirius Laboratories Oral composition and method for the treatment of inflammatory cutaneous disorders
WO2004067018A1 (en) * 2003-01-30 2004-08-12 Council Of Scientific And Industrial Research Bioavailability enhancing activity of carum carvi extracts and fractions thereof
AU2003223111A1 (en) 2003-03-31 2004-10-25 Council Of Scientific And Industrial Research Use of cuminum cyminum extract and piperine for potentiation of bioefficacy of anti infectives
US7119075B2 (en) * 2003-03-31 2006-10-10 Council Of Scientific And Industrial Research Use of herbal agents for potentiation of bioefficacy of anti infectives
US7160565B2 (en) * 2003-03-31 2007-01-09 Breakthru Products, Llc Hydration beverage and method of delivering nutrients
US8703209B2 (en) * 2003-06-17 2014-04-22 Edward Larry McCleary Composition and method for modulating hydrogen ion physiology
EP1875816A3 (en) * 2003-07-10 2008-03-12 Carl A. Forest Beverages with specialized supplements
JP4012894B2 (ja) * 2003-09-17 2007-11-21 レキオファーマ株式会社 ウコン含有組成物
JP4797363B2 (ja) * 2003-11-13 2011-10-19 大正製薬株式会社 高血圧改善剤
US20080160086A1 (en) * 2004-02-19 2008-07-03 Scepter Holdings, Inc. Delivery Systems For Calcium
US20050276839A1 (en) * 2004-06-10 2005-12-15 Rifkin Calman H Appetite satiation and hydration beverage
EP1719519B1 (de) * 2005-02-24 2007-10-24 PM-International AG Nahrungsergänzungsmittelpräparat-Set
US20060198906A1 (en) * 2005-03-07 2006-09-07 Sami Labs Limited Compositions and Method to Increase Serum Levels of HDL cholesterol and Lower the Risk of Cardiovascular Disease
US8021701B1 (en) 2005-04-13 2011-09-20 Perry Stephen C Composition to retard the onset of symptoms of alzheimer's disease
FR2887748B1 (fr) * 2005-06-29 2009-09-04 Physcience Soc Par Actions Sim Complement alimentaire et son utilisation pour la prevention ou la lutte contre les effets des affections articulaires.
FR2887749B1 (fr) * 2005-06-29 2009-09-04 Physcience Soc Par Actions Sim Complement alimentaire et son utilisation pour la prevention ou la lutte contre les effets des affections articulaires
DE102005043986A1 (de) * 2005-09-14 2007-04-05 Mark Warnecke Zusatznahrungsmittel
JP2009510087A (ja) * 2005-09-30 2009-03-12 オーエムピー インコーポレーテッド 安定アスコルビン酸組成物
US20070116852A1 (en) * 2005-11-22 2007-05-24 Josef Schnatmann Cattle feed preparation
US20070269534A1 (en) * 2006-02-02 2007-11-22 Ramirez Jose E Methods of treating skin to enhance therapeutic treatment thereof
US20070178058A1 (en) * 2006-02-02 2007-08-02 Ramirez Jose E Methods of using stable ascorbic acid compositions
PL2134351T3 (pl) 2007-03-13 2017-10-31 Jds Therapeutics Llc Sposoby i kompozycje do przedłużonego uwalniania chromu
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
EP2011495A1 (en) * 2007-07-03 2009-01-07 Sygnis Bioscience GmbH & Co. KG Use of piperine and derivatives thereof for the therapy of neurological conditions
WO2009020868A2 (en) 2007-08-04 2009-02-12 Rezzorb, Llc Method and apparatus for reducing fertilizer use in agricultural operations
US20090062231A1 (en) * 2007-08-31 2009-03-05 O'mara Ann Marie Appetite Suppressant Composition and Method of Appetite Suppression
US20090297622A1 (en) * 2008-01-01 2009-12-03 Khorshid Faten A Separation and formulation of bioactive fraction and subfraction from camel urine work as anticancer agent
KR101078376B1 (ko) * 2009-02-02 2011-10-31 연세대학교 산학협력단 피페린 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 비만 예방 및 치료용 조성물
US8247435B2 (en) * 2009-02-19 2012-08-21 Thornthwaite Jerry T Formulations for treating human and animal diseases
WO2010124269A1 (en) * 2009-04-24 2010-10-28 National Center For Genome Resources Methods for diagnosis of sepsis and risk of death
ES2547466T3 (es) 2009-06-17 2015-10-06 Fatin A. Khorshid Separación y formulación de fracción bioactiva y trabajo de subfracción de orina de camello como agente anticáncer
EP2289528A1 (en) 2009-07-21 2011-03-02 DSM IP Assets B.V. Novel nutraceutical compositions containing black pepper or its constituents improving mental performance
AP2012006117A0 (en) * 2009-07-23 2012-02-29 Cadila Pharmaceuticals Ltd Pharmaceutical composition of rifampicin.
JP2011073973A (ja) * 2009-09-29 2011-04-14 Shiseido Co Ltd 更年期のための疲労改善組成物
GB201002314D0 (en) * 2010-02-11 2010-03-31 Gomez Richard N C Dietary supplement composition
GB201002318D0 (en) * 2010-02-11 2010-03-31 Gomez Richard N C Dietary supplement composition
JP2012070726A (ja) * 2010-08-31 2012-04-12 Toyo Shinyaku Co Ltd バイオアベイラビリティを高めた美容食品用組成物
JP2012051833A (ja) * 2010-08-31 2012-03-15 Toyo Shinyaku Co Ltd 血流改善用組成物
KR101281827B1 (ko) * 2011-03-25 2013-07-03 (주)풀무원홀딩스 피페린을 유효성분으로 포함하는 인삼 사포닌 흡수 촉진용 조성물
US8840938B2 (en) * 2011-04-13 2014-09-23 W. Matthew Warnock Bioavailability enhancing composition
WO2012145369A1 (en) * 2011-04-22 2012-10-26 Faerstein Paul Joseph Compositions and methods for nutritional supplementation
EP2804587B1 (en) 2012-01-19 2019-05-08 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Formulation and method for increasing oral bioavailability of drugs
US10485258B2 (en) 2012-05-01 2019-11-26 Board Of Trustees, Rutgers, The State University Of New Jersey Production of enriched products
JP6760710B2 (ja) * 2013-09-13 2020-09-23 大正製薬株式会社 飲料
AU2016244997B2 (en) 2013-11-01 2021-08-05 Rutgers, The State University Of New Jersey Extracts from plants of the Moringaceae family and methods of making
US20160243176A1 (en) 2013-11-01 2016-08-25 Rutgers, The State University Of New Jersey Extracts from plants of the moringaceae family and methods of making
US11865121B2 (en) 2016-02-11 2024-01-09 Nutrition21, LLC Chromium containing compositions for improving health and fitness
IT201600128994A1 (it) * 2016-12-20 2018-06-20 Inpha Duemila Srl Formulazioni per uso nel trattamento dell’endometriosi e dei disturbi ad essa associati
US10456401B2 (en) 2017-05-12 2019-10-29 Innovus Pharmaceuticals, Inc. Therapeutic methods and compositions
EP3651804B1 (de) * 2017-07-11 2023-08-23 Aquanova AG Solubilisat mit curcumin und boswellia und xanthohumol
WO2019073491A1 (en) 2017-10-14 2019-04-18 Cipla Limited PROCESS FOR THE PREPARATION OF SUBSTANTIALLY PURE PIPERINE
US10500199B2 (en) 2017-12-01 2019-12-10 Innovus Pharmaceuticals, Inc. Nutritional supplement for increasing cognitive functions
US10864205B2 (en) * 2017-12-01 2020-12-15 Innovus Pharmaceuticals, Inc. Nutritional supplement for improving sexual health in men and women
US20190167699A1 (en) 2017-12-01 2019-06-06 Innovus Pharmaceuticals, Inc. Prostate function support formula
US10758505B2 (en) * 2017-12-01 2020-09-01 Innovus Pharmaceuticals, Inc. Therapeutic compositions and methods
DE102018101778A1 (de) * 2018-01-26 2019-08-01 Lts Lohmann Therapie-Systeme Ag Mehrschichtiger Oraler Dünnfilm
RS64651B1 (sr) 2018-07-11 2023-10-31 Aquanova Ag Solubilizat ksantohumola
WO2020081357A1 (en) * 2018-10-16 2020-04-23 Golden Spice Liquors LLC Beverage compositions and methods of making and using the same
US10849948B2 (en) 2019-04-16 2020-12-01 The Procter & Gamble Company Supplement for menopause
IL271778A (en) 2019-12-31 2021-06-30 Ichilov Tech Ltd Methods for treating atopic dermatitis
JP7162357B2 (ja) * 2020-10-02 2022-10-28 株式会社山田養蜂場本社 桂皮酸誘導体の吸収促進剤
CN116602405B (zh) * 2023-05-18 2024-05-28 北京康比特体育科技股份有限公司 含黑胡椒提取物的组合物在制备促进肌肉蛋白质合成及缓解和/或消除炎症的产品中的应用
CN117958426A (zh) * 2024-01-31 2024-05-03 武汉森澜生物科技有限公司 含荜茇和黑胡椒的营养素生物利用度促进剂和制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284657A (en) * 1980-01-09 1981-08-18 Kraf, Inc. Fluidized oleoresin compositions
US5744161A (en) * 1995-02-24 1998-04-28 Sabinsa Corporation Use of piperine as a bioavailability enhancer

Also Published As

Publication number Publication date
DE69522477D1 (de) 2001-10-04
GR3036711T3 (en) 2001-12-31
PT810868E (pt) 2002-02-28
EP0810868B1 (en) 2001-08-29
EP0810868A1 (en) 1997-12-10
WO1996025939A1 (en) 1996-08-29
US5972382A (en) 1999-10-26
CA2247467C (en) 2007-05-29
JPH11500725A (ja) 1999-01-19
CA2247467A1 (en) 1996-08-29
EP0810868A4 (en) 1998-11-25
DE69522477T2 (de) 2002-05-29
AU4128796A (en) 1996-09-11
ATE204757T1 (de) 2001-09-15
US5744161A (en) 1998-04-28
DK0810868T3 (da) 2001-11-26
JP3953513B2 (ja) 2007-08-08

Similar Documents

Publication Publication Date Title
ES2161914T3 (es) Uso de piperina como mejorador de la absorcion gastrointestinal.
TW352384B (en) Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals
IL89835A0 (en) Substituted azetidinones,their preparation and pharmaceutical compositions containing them
NZ306664A (en) Intermediates of camptothecin (CPT-11) or mappicine and their manufacture
HK1015788A1 (en) Chiral methylphenyloxazolidinones
SE9702001D0 (sv) Novel compounds
PT921787E (pt) Regime de administracao de inibidores de atpase de h',k'
UA49884C2 (uk) ПОХІДНІ <font face="Symbol">a</font>-ГІДРОКСИКАРБОНОВОЇ КИСЛОТИ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
MXPA02009643A (es) Sintesis acortada de derivados de 3,3-diarilpropilamina.
AU6270298A (en) Zonula occludens toxin receptors
GEP20063972B (en) Streptogramin derivatives, preparation and compositions containing them
UA35607C2 (uk) Похідні оксазолідинонкарбонової кислоти, спосіб їх одержання, фармацевтична композиція і спосіб її одержання
NZ325235A (en) New phenylamidine derivatives, a process for preparing the same and their use as medicaments
MD502F1 (en) New adenozin derivatives, method for preparation, pharmaceutical baze compositions
YU12000A (sh) Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova
AU2003271811A8 (en) Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulphonates) and compositions containing same
PL328123A1 (en) Derivatives of banzo[c]quinolysine and method of obtaining them
ZA949563B (en) Method for treating aphthae using dimeticone.
AU2003227717A1 (en) 17Alpha-FLUOROALKYL-11Beta-BENZALDOXIME-STEROIDS, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING SAID STEROIDS AND THE USE THEREOF IN THE PRODUCTION OF MEDICAMENTS
EP0631474A4 (en) Cyclic anti-tumor promoter compounds, compositions and methods for production and use.
HUP9901600A3 (en) Vitamin d analogues, their use, pharmaceutical compositions containing them, process for their production and process producing intermediates
IL135364A0 (en) Vitamin d derivatives, processes for the production thereof and for producing pharmaceutical compositions containing the same
HUP0003429A1 (hu) Kamptotecin optikailag tiszta analógjai, és az azokat tartalmazó gyógyszerkészítmények, optikailag tiszta szintetikus közbenső termékek és eljárás azok előállítására
HK1051845A1 (en) Substituted 1 and 2 naphthol mannich bases
BG100779A (en) Derivatives of 12.13-epoxytylosin and methods for their preparation

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 810868

Country of ref document: ES